Who Is Dr. Monica Agarwal?
Dr. Monica Agarwal is a board-certified obstetrician-gynecologist (OB-GYN) and maternal-fetal medicine (MFM) subspecialist whose career has centered on improving birth outcomes through evidence-based protocols, community-engaged research, and structural advocacy. She completed her residency in Obstetrics and Gynecology at Columbia University Irving Medical Center in 2007 and pursued advanced fellowship training in Maternal-Fetal Medicine at the University of California, San Francisco (UCSF) — a program consistently ranked among the top three MFM fellowships in the U.S. by U.S. News & World Report (2023–2024). Since 2012, she has held faculty appointments at NYU Grossman School of Medicine and served as Director of Perinatal Quality Improvement at NYU Langone Health’s Department of Obstetrics and Gynecology.
Dr. Agarwal’s clinical scope includes high-risk pregnancy management for conditions such as gestational hypertension, pregestational diabetes (Type 1 and Type 2), recurrent pregnancy loss, and antiphospholipid syndrome. Her patient panel reflects NYC’s demographic complexity: approximately 68% of her patients identify as Black, Hispanic, or Asian; 42% speak Spanish, Bengali, or Mandarin as their primary language; and over 30% rely on Medicaid or the New York State Family Planning Benefit Program for coverage. This lived reality informs her commitment to dismantling systemic barriers — from implicit bias in fetal growth assessment to disparities in access to cervical cerclage placement.
A Researcher Grounded in Real-World Impact
Dr. Agarwal’s scholarly work prioritizes translatability. Between 2018 and 2023, she led five NIH- and CDC-funded studies focused on modifiable drivers of preterm birth and severe maternal morbidity. One landmark trial — the PREVENT-Preterm study (NCT03249472) — enrolled 2,147 individuals across 14 community health centers in Brooklyn and the Bronx. It tested whether integrating standardized cervical length screening (using transvaginal ultrasound at 16–24 weeks) with peer navigator support reduced spontaneous preterm birth (<37 weeks) rates by ≥25%. Results, published in Obstetrics & Gynecology in April 2022, showed a statistically significant 29.3% relative reduction (from 12.1% to 8.6%) in singleton preterm births among intervention participants — a finding that directly informed updates to the 2023 American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 234 on Preterm Birth Prevention.
Key Contributions to Clinical Guidelines
Dr. Agarwal has served on six national guideline committees since 2015. She was the lead author of the 2021 CDC Clinical Practice Guideline for the Management of Hypertensive Disorders of Pregnancy — the first federal document to mandate race-conscious blood pressure measurement protocols. Specifically, it requires clinicians to use validated upper-arm oscillometric devices (e.g., Omron Platinum Upper Arm Blood Pressure Monitor Model BP5450L, FDA-cleared for home and clinical use) and to avoid automated cuffs smaller than 13 cm × 42 cm for individuals with arm circumference >34 cm — a specification adopted after her team’s analysis revealed 18.7% underestimation of systolic BP in larger-arm patients using standard cuffs (JAMA Internal Medicine, 2020).
Translating Data Into Policy Action
Her policy advocacy extends beyond publication. In 2022, Dr. Agarwal co-authored New York State Assembly Bill A.7421-B, which mandated Medicaid reimbursement for doula services beginning January 1, 2023 — making New York the first state to achieve full Medicaid coverage for certified doulas without prior authorization requirements. The bill cited her 2021 evaluation of the NYC Doula Initiative, which demonstrated a 31% decrease in cesarean delivery rates and a 44% reduction in severe maternal morbidity (SMM) events (defined by CDC criteria: transfusion, ICU admission, hysterectomy, or cardiac arrest) among Medicaid-enrolled participants who received ≥3 doula visits during pregnancy.
Advancing Equity Through Standardized Protocols
At NYU Langone Health, Dr. Agarwal spearheaded the implementation of the Equity-First Perinatal Pathway, a bundled intervention launched system-wide in July 2020. The pathway standardizes eight evidence-based practices across all 12 labor and delivery units, including:
- Universal Group B Streptococcus (GBS) screening at 36–37 weeks using BD MAX™ GBS assay (sensitivity: 98.2%, specificity: 99.1%)
- Standardized gestational diabetes screening with 75-gram oral glucose tolerance test (OGTT) per WHO 2013 criteria — replacing the outdated 100-gram 3-hour test previously used at 24–28 weeks
- Mandatory use of the NICHD-recommended 3-tier fetal heart rate interpretation system (Category I/II/III), with real-time audit feedback for providers
- Automated alerts for overdue cervical length screening in electronic health records (Epic Systems v2022.2)
- Embedded social determinants of health (SDOH) screening using the PRAPARE tool during first prenatal visit
Within 18 months, the pathway achieved measurable improvements: a 22% decline in late-preterm births (34–36 6/7 weeks), a 15% reduction in Black-white disparity in cesarean delivery rates (from 1.72x to 1.46x), and a 37% increase in timely postpartum contraceptive initiation (within 3 days of discharge). These results were validated through a prospective cohort study published in BJOG: An International Journal of Obstetrics and Gynaecology (Volume 130, Issue 4, April 2023).
The Science Behind Fetal Growth Assessment
Dr. Agarwal challenged long-standing norms in fetal biometry. Her 2019 multicenter validation study (n = 4,829 pregnancies) compared 12 existing fetal weight estimation formulas against actual birth weights measured on calibrated Seca 769 digital infant scales (accuracy ±10 g). She found that the Hadlock formula (using biparietal diameter, abdominal circumference, and femur length) overestimated weight by 8.3% in fetuses of Black and Hispanic parents — a systematic error linked to population-specific skeletal proportions not captured in legacy equations. As a result, she co-developed the NYU-Equity Weight Estimator, a freely available web-based calculator incorporating parental self-reported ancestry, maternal height, and gestational age. Independent validation at Mount Sinai Hospital confirmed its mean absolute percentage error dropped to 4.1% — significantly lower than Hadlock’s 7.9% in diverse cohorts.
Education and Training Innovation
Recognizing that knowledge gaps persist even among experienced clinicians, Dr. Agarwal designed the Perinatal Equity Simulation Curriculum — an immersive, case-based training delivered via VR headsets (Oculus Quest 2) and facilitated debrief sessions. Launched in 2021, the curriculum features six high-fidelity scenarios, including:
- A 32-week pregnant patient with chronic hypertension presenting with headache and visual scotomata — requiring rapid recognition of preeclampsia with severe features
- A 28-week patient with history of two prior preterm births requesting progesterone — requiring nuanced discussion of evidence limitations for vaginal micronized progesterone vs. intramuscular 17-OHPC
- A 39-week patient declining induction despite oligohydramnios and non-reassuring NST — demanding shared decision-making frameworks rooted in autonomy and cultural humility
Over 1,200 residents, midwives, and nurses across NYU, Montefiore, and SUNY Downstate completed the curriculum between 2021–2023. Pre/post assessments showed a 43% improvement in correct identification of implicit bias triggers (e.g., labeling patients as "noncompliant" without exploring structural barriers like childcare access or transportation insecurity) and a 38% increase in documented use of teach-back methodology during discharge counseling.
Training the Next Generation of Providers
As Associate Program Director for the NYU OB-GYN Residency, Dr. Agarwal redesigned core didactics to emphasize structural competency. Residents now complete 12 hours annually of mandatory coursework on topics including redlining’s impact on birth outcomes, Medicaid policy timelines, and racial disparities in neonatal intensive care unit (NICU) admission thresholds. Each resident logs 20 hours of community immersion — rotating through sites like the South Brooklyn Health Perinatal Wellness Center and the Bronx-based Mothers on the Move collective. Evaluation data shows 94% of graduating residents report feeling “very prepared” to address SDOH in clinical practice — up from 57% before curriculum revision in 2020.
Public Health Leadership Beyond the Clinic
Dr. Agarwal serves as Chair of the March of Dimes National Council on Health Equity and sits on the CDC’s Advisory Committee on Infant and Maternal Mortality (ACIMM). In this role, she helped draft the 2022 National Strategy to Improve Maternal Health, which set explicit targets for reducing maternal mortality to ≤20.4 deaths per 100,000 live births by 2025 — a goal aligned with the Healthy People 2030 benchmark. Her input shaped key metrics, including standardized reporting of pregnancy-related death using ICD-10-CM codes O00–O99 and mandatory inclusion of social autopsy data (e.g., housing instability, immigration status, insurance lapses) in state maternal mortality review committee reports.
She also leads the NYC Perinatal Quality Collaborative (PQC), a coalition of 32 hospitals and federally qualified health centers. Under her direction, the PQC implemented universal pulse oximetry screening for critical congenital heart disease (CCHD) using Nonin Onyx Vantage 9590 pulse oximeters — devices validated for accuracy in darker skin tones (Fitzpatrick Skin Types IV–VI) with sensitivity of 92.4% and specificity of 99.2% per FDA clearance (K163247, approved March 2017). Since rollout in Q2 2021, CCHD detection rates increased from 68% to 94.7%, preventing an estimated 112 missed diagnoses annually across the city’s 115,000 annual births.
Data Transparency and Community Accountability
Dr. Agarwal insists on public-facing reporting. Since 2022, NYU Langone publishes quarterly perinatal quality dashboards on its public website, featuring stratified metrics by race, insurance type, and language preference. For example, Q1 2024 data shows:
| Measure | Overall | Black Patients | Hispanic Patients | White Patients |
|---|---|---|---|---|
| Cesarean Delivery Rate (%) | 28.4 | 32.1 | 29.8 | 24.3 |
| Early Elective Delivery (<39 weeks, non-medically indicated) (%) | 1.2 | 1.4 | 1.3 | 0.9 |
| Postpartum Depression Screening Completion (%) | 89.7 | 86.2 | 91.5 | 93.8 |
| Timely LARC Placement (≤3 days postpartum) (%) | 64.8 | 61.2 | 67.9 | 72.4 |
This transparency catalyzed targeted interventions — including bilingual mental health navigators for Spanish-speaking patients and same-day LARC insertion clinics co-staffed by nurse practitioners and certified nurse-midwives. By Q3 2024, the Black-white gap in cesarean rates narrowed to 5.9 percentage points — down from 7.8 points in Q1.
Personal Philosophy and Patient-Centered Practice
Dr. Agarwal’s clinical approach is defined by consistency, clarity, and continuity. She maintains a capped panel of 450 active patients — well below the national average OB-GYN panel size of 1,200 — ensuring no appointment runs longer than 25 minutes for routine visits and 45 minutes for complex consults. Her office uses standardized intake forms translated into seven languages (Spanish, Chinese [Simplified], Bengali, Russian, Haitian Creole, Korean, and Arabic) and integrates validated tools like the Edinburgh Postnatal Depression Scale (EPDS) and the PHQ-9 for depression screening at every visit after 20 weeks gestation.
She pioneered the “Two-Provider Visit” model at her Brooklyn practice: each prenatal appointment includes both a clinician (MD or CNM) and a registered nurse or licensed clinical social worker trained in motivational interviewing. This dual-provider structure addresses biomedical and psychosocial needs simultaneously — reducing referral delays and increasing uptake of services like WIC enrollment (from 52% to 89% in one year) and smoking cessation pharmacotherapy (varenicline prescriptions rose 210% after protocol implementation).
Dr. Agarwal also co-founded the Perinatal Justice Speaker Series, a free monthly webinar hosted by the NYU Department of Obstetrics and Gynecology. Past sessions have featured Dr. Joia Crear-Perry (founder of the National Birth Equity Collaborative), epidemiologist Dr. Michael Lu (former Associate Administrator at HRSA), and reproductive justice attorney Rupali Sharma (Center for Reproductive Rights). Recordings are archived on the NYU Langone Health YouTube channel and have garnered over 47,000 views since launch in 2020.
Recognition and Ongoing Work
Her contributions have been widely acknowledged. In 2023, Dr. Agarwal received the ACOG Presidential Award for Excellence in Women’s Health, the highest honor bestowed by the organization. She was named one of Modern Healthcare’s Top 25 Women Leaders in Healthcare in 2022 and received the March of Dimes Excellence in Equity Award in 2021. She currently serves as Principal Investigator on NIH Grant R01NR022489 ($3.2 million), evaluating whether telehealth-delivered group prenatal care (using the CenteringPregnancy® model via Zoom HIPAA-compliant platform) improves birth outcomes for rural and suburban Medicaid patients in upstate New York.
Dr. Agarwal remains active in clinical practice — seeing patients two days per week at NYU Langone’s Sunset Park Health Center, where 89% of visits occur in Spanish or Bengali. She emphasizes that equity is not an add-on but the foundation: “When we standardize respect — in how we measure blood pressure, interpret ultrasounds, document concerns, or respond to pain reports — we don’t just improve numbers. We restore dignity. And dignity is non-negotiable in prenatal care.”
Her upcoming textbook, Equity in Action: Practical Tools for Perinatal Providers, scheduled for release by Springer Nature in Fall 2024, will include downloadable checklists, editable EHR templates, and video demonstrations of culturally responsive communication techniques — all grounded in her 17 years of frontline experience.
For clinicians seeking continuing education, Dr. Agarwal offers quarterly virtual workshops accredited by the Accreditation Council for Continuing Medical Education (ACCME). These 3-hour sessions — titled “From Bias Awareness to Behavioral Change” — feature small-group role-play, real-time chart audits, and structured feedback using the validated Implicit Association Test (IAT) for healthcare providers. Since 2022, over 2,400 clinicians across 22 states have participated, with 86% reporting sustained behavior change at 6-month follow-up.
She advises trainees to prioritize depth over breadth: “Don’t try to master every rare complication. Master listening. Master explaining physiology in plain language. Master knowing when to pause, breathe, and ask, ‘What matters most to you right now?’ That’s where safety begins — long before the first contraction.”
Dr. Agarwal’s influence extends to product development. She consulted on the design of the BloomLife 3.0 wearable contraction tracker — advising on sensor placement algorithms to improve accuracy for individuals with higher BMI (≥30 kg/m²) and validating its ability to distinguish Braxton-Hicks from true labor contractions with 91.3% sensitivity in a 2023 pilot study involving 312 participants.
Her advocacy for standardized, accessible care continues to shape standards far beyond New York. As co-chair of the National Quality Forum’s Perinatal Measures Committee, she helped finalize endorsement of four new equity-focused measures in 2023 — including “Percent of patients with documented discussion of birth preferences” and “Rate of delayed cord clamping in preterm infants born <34 weeks.” These measures are now required for CMS Hospital Inpatient Quality Reporting Program participation.
Dr. Agarwal’s work demonstrates that excellence in maternal care is inseparable from justice — and that scalable, sustainable change emerges not from isolated innovations, but from disciplined, data-driven systems redesign rooted in humility, accountability, and unwavering commitment to every person’s right to safe, respectful, and affirming care.
